Ultrasound-Guided Dextrose Injection Treatment for Persistent Chest Wall and Axillary Pain in Female Breast Cancer Survivors

What this Trial Is About

Researchers are evaluating ultrasound-guided dextrose prolotherapy in female breast cancer survivors who experience persistent chest wall and axillary pain and tightness that has not improved with standard physical therapy. This study aims to assess the safety, feasibility, and preliminary effects of this treatment on upper extremity function, pain levels, shoulder movement, and chest wall tightness. Participants will receive three sessions of ultrasound-guided injections of a 5% dextrose solution targeted at specific soft-tissue areas in the chest and axilla. These injections occur at four-week intervals. Throughout the six-month study, participants continue their usual rehabilitation program, including exercises for range of motion, stretching, and strengthening. During the study, participants undergo baseline physical exams and ultrasound assessments, followed by regular follow-ups every four weeks during treatment and additional check-ins at three and six months after the last injection. Researchers will measure functional ability, pain intensity, shoulder range of motion, and tissue tightness to evaluate treatment effects and response durability.

Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.